Estrogen and estrogen–progestin replacement therapy and risk of postmenopausal breast cancer in Canada

By Kirsh V.  

Cancer Causes and Control, Vol. 13, Iss. 6, 2002-08 ,pp. : 583-590

Springer Publishing Company

Access to resources Recommend Favorite

Estrogen Receptor  lpar; ESR2 ) Polymorphisms and Endometrial Cancer (United States)

By Setiawan Veronica Wendy  

Cancer Causes and Control, Vol. 15, Iss. 6, 2004-08 ,pp. : 627-633

Springer Publishing Company

Access to resources Recommend Favorite

Estrogen–progestin replacement therapy and breast cancer risk: the Women's Health Study (United States)

By Porch J.V.  

Cancer Causes and Control, Vol. 13, Iss. 9, 2002-11 ,pp. : 847-854

Springer Publishing Company

Access to resources Recommend Favorite

Endometrial cancer in Asian migrants to the United States and their descendants

By Liao C.K.  

Cancer Causes and Control, Vol. 14, Iss. 4, 2003-05 ,pp. : 357-360

Springer Publishing Company

Access to resources Recommend Favorite

Progestin therapy for endometrial cancer: The potential of fourth-generation progestin (Review)

By Banno Kouji   Kisu Iori   Yanokura Megumi   Tsuji Kosuke   Masuda Kenta   Ueki Arisa   Kobayashi Yusuke   Yamagami Wataru   Nomura Hiroyuki   Susumu Nobuyuki   Aoki Daisuke  

International Journal of Oncology, Vol. 40, Iss. 6, 2012-06 ,pp. : 1755-1762

Spandidos Publications

Access to resources Recommend Favorite